bay-k-8644 and mdl 100907

bay-k-8644 has been researched along with mdl 100907 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bova, S; Fusi, F; Saponara, S; Sgaragli, G; Spiga, O; Trezza, A	1

Other Studies

1 other study(ies) available for bay-k-8644 and mdl 100907

Article	Year
Ritanserin blocks Ca Acta pharmacologica Sinica, 2020, Volume: 41, Issue:9 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Binding Sites; Calcium Channels, L-Type; Electrophysiological Phenomena; Ketanserin; Male; Molecular Docking Simulation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Binding; Rats, Wistar; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction	2020

Article

Year

Ritanserin blocks Ca

Acta pharmacologica Sinica, 2020, Volume: 41, Issue:9

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Binding Sites; Calcium Channels, L-Type; Electrophysiological Phenomena; Ketanserin; Male; Molecular Docking Simulation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Binding; Rats, Wistar; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction

2020